<DOC>
	<DOCNO>NCT00916474</DOCNO>
	<brief_summary>Observational follow-up study ass long-term response telaprevir evaluate change Hepatitis C virus time .</brief_summary>
	<brief_title>Virology Follow Study Subjects Previously Treated With Telaprevir</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Received least 1 dose telaprevirbased treatment 1 follow clinical study : VX05950104 , VX05950104EU , VX06950106 , VX06950107 , VX07950108 , VX08950111 , VX950TiDP24C216 Have baseline HCV viral sequence data available previous telaprevir study May currently participate antiviral followup period ongoing telaprevir trial . ( Note : Subjects complete required antiviral followup period still participate collection patientreported outcome data previous telaprevir study may eligible . ) For subject participate ongoing study time enrollment , 90 elapse day database lock unblinding previous telaprevir study Day 1 study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>